Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Holstein

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Acta Diabetologica|May 8, 2018
Permanent brain damage following parasuicide with severe insulin-induced hypoglycaemiaAndreas Holstein, Markus Zimmer, Mathias Rohde, et al.
Aging Clinical and Experimental Research|November 14, 2014
Unusual neurological manifestation of severe digitoxin intoxication with bilateral ballism and visual hallucinationsAndreas Holstein, Ahmad Hassan, Olaf M Patzer, et al.
BMC Medical Genetics|February 26, 2011
TCF7L2 and therapeutic response to sulfonylureas in patients with type 2 diabetesAndreas Holstein, Michael Hahn, Antje Körner, et al.
Pharmacogenomics|December 20, 2011
The Ser1369Ala variant of ABCC8 and the risk for severe sulfonylurea-induced hypoglycemia in German patients with Type 2 diabetesJudith Dina Holstein, Peter Kovacs, Olaf Patzer, et al.
Journal of Gastroenterology and Hepatology|July 9, 2002
Clinical implications of hepatogenous diabetes in liver cirrhosisAndreas Holstein, S Hinze, E Thiessen, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 28, 2017
Self-reported Hypoglycaemic Events in 2 430 Patients with Insulin-treated Diabetes in the German Sub-population of the HAT StudyWerner Kern, Andreas Holstein, Christian Moenninghoff, et al.
Expert Opinion on Drug Safety|June 18, 2010
Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patientsAndreas Holstein, Claude Hammer, Michael Hahn, et al.
European Journal of Clinical Pharmacology|January 8, 2011
Impact of clinical factors and CYP2C9 variants for the risk of severe sulfonylurea-induced hypoglycemiaAndreas Holstein, Michael Hahn, Olaf Patzer, et al.
Journal of Gastroenterology and Hepatology|May 27, 2006
Autoantibody profiles in microscopic colitisAndreas Holstein, Joerg Burmeister, Armin Plaschke, et al.
Diabetes Care|March 14, 2012
Substantial increase in incidence of severe hypoglycemia between 1997-2000 and 2007-2010: a German longitudinal population-based studyAndreas Holstein, Olaf M Patzer, Kathrin Machalke, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Acta Diabetologica|May 8, 2018
Permanent brain damage following parasuicide with severe insulin-induced hypoglycaemiaAndreas Holstein, Markus Zimmer, Mathias Rohde, et al.
Aging Clinical and Experimental Research|November 14, 2014
Unusual neurological manifestation of severe digitoxin intoxication with bilateral ballism and visual hallucinationsAndreas Holstein, Ahmad Hassan, Olaf M Patzer, et al.
BMC Medical Genetics|February 26, 2011
TCF7L2 and therapeutic response to sulfonylureas in patients with type 2 diabetesAndreas Holstein, Michael Hahn, Antje Körner, et al.
Pharmacogenomics|December 20, 2011
The Ser1369Ala variant of ABCC8 and the risk for severe sulfonylurea-induced hypoglycemia in German patients with Type 2 diabetesJudith Dina Holstein, Peter Kovacs, Olaf Patzer, et al.
Journal of Gastroenterology and Hepatology|July 9, 2002
Clinical implications of hepatogenous diabetes in liver cirrhosisAndreas Holstein, S Hinze, E Thiessen, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 28, 2017
Self-reported Hypoglycaemic Events in 2 430 Patients with Insulin-treated Diabetes in the German Sub-population of the HAT StudyWerner Kern, Andreas Holstein, Christian Moenninghoff, et al.
Expert Opinion on Drug Safety|June 18, 2010
Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patientsAndreas Holstein, Claude Hammer, Michael Hahn, et al.
European Journal of Clinical Pharmacology|January 8, 2011
Impact of clinical factors and CYP2C9 variants for the risk of severe sulfonylurea-induced hypoglycemiaAndreas Holstein, Michael Hahn, Olaf Patzer, et al.
Journal of Gastroenterology and Hepatology|May 27, 2006
Autoantibody profiles in microscopic colitisAndreas Holstein, Joerg Burmeister, Armin Plaschke, et al.
Diabetes Care|March 14, 2012
Substantial increase in incidence of severe hypoglycemia between 1997-2000 and 2007-2010: a German longitudinal population-based studyAndreas Holstein, Olaf M Patzer, Kathrin Machalke, et al.
Pageof 4